Evidence-Based Benefits
- Blood sugar regulation — a 2014 meta-analysis of 25 RCTs found chromium supplementation significantly reduced fasting glucose (-0.95 mg/dL) and HbA1c (-0.54%) in type 2 diabetes patients
- Insulin sensitivity — chromium enhances insulin receptor signaling by amplifying tyrosine kinase activity, improving cellular glucose uptake
- Body composition — a 2013 meta-analysis found chromium picolinate produced a modest reduction in body weight (-0.5 kg) compared to placebo, though clinical significance is debatable
- Lipid metabolism — some studies show modest reductions in total cholesterol and triglycerides with chromium supplementation
- Carbohydrate craving reduction — a 2008 Dye et al. study found 1,000mcg chromium picolinate reduced carbohydrate cravings in individuals with atypical depression